Korean J Physiol Pharmacol.  2015 Sep;19(5):473-478. 10.4196/kjpp.2015.19.5.473.

The Inhibitory Mechanism of Gentamicin on Electrical Field Stimulation Response in Rat Bladder Smooth Muscle

Affiliations
  • 1Department of Pharmacology, College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea. udsohn@cau.ac.kr

Abstract

To see the inhibitory mechanism of gentamicin in response to electrical field stimulation (EFS) using the rat bladder smooth muscle, atropine or guanethidine was treated but had no effect. Methylsergide, a non-selective 5-HT1, 5-HT2 receptor antagonist was also treated but had on effect. Kinase inhibitors, such as chelerythrine (PKC inhibitor), ML-9 (MLCK inhibitor), or Y27632 (rho kinase inhibitor) were pretreated before gentamicin treatment, but did not have effect. For U73122, a phospholipase C (PLC) inhibitor however, the inhibitory effect to gentamicin was significantly attenuated in all frequencies given by the EFS. Therefore gentamicin induced inhibitory effect on EFS response in rat bladder smooth muscle was not mediated by the activation of adrenergic, cholinergic, or serotonergic receptor. The inhibition of gentamicin might be mediated through the PLC dependent pathway, but not through the PKC, MLCK or rho kinase dependent pathway.

Keyword

EFS; Gentamicin; Phospholipase C; Smooth muscle

MeSH Terms

Animals
Atropine
Gentamicins*
Guanethidine
Muscle, Smooth*
Phosphotransferases
Rats*
rho-Associated Kinases
Type C Phospholipases
Urinary Bladder*
Atropine
Gentamicins
Guanethidine
Phosphotransferases
Type C Phospholipases
rho-Associated Kinases

Figure

  • Fig. 1 Representative tracing showing the effect of gentamycin on EFS in the rat bladder smooth muscle. Gentamicin was added cumulatively with an interval of 5 min. The tone was measured under the EFS of 1, 2, 4, 6, 8 Hz. Each point represents the mean±SE (n=8).

  • Fig. 2 Effect of atropine, guanethidine and methylsergide on EFS in rat bladder smooth muscle treated with gentamicin. Atropine (0.1 mM), guanethidine (0.1 mM) or rmethylsergide (10 µM) was treated 30 min prior to EFS stimulation. The tone was measured under the EFS of 1~8 Hz. Each point represents the mean±SE (n=8).

  • Fig. 3 Effect of chelerythrine, ML-9 and Y27632 on EFS in rat bladder smooth muscle treated with gentamicin. Chelerythrine (10 µM), ML-9 (10 µM) and Y27632 (1 µM) was treated 30 min prior to EFS stimulation. The tone was measured under the EFS of 1~8 Hz. Each point represents the mean±SE (n=8).

  • Fig. 4 Effect of U73122 on EFS in rat bladder smooth muscle treated with gentamicin. U73122 (1 µM) was treated 30 min prior to EFS stimulation. For each concentration the tone was measured under the EFS of 1~8 Hz. Each point represents the mean±SE (n=8). *p<0.05, **p<0.01 vs. control.


Cited by  1 articles

The change of signaling pathway on the electrical stimulated contraction in streptozotocin-induced bladder dysfunction of rats
Jong Soo Han, Young Sil Min, Gil Hyung Kim, Sang-hyun Chae, Yoonjin Nam, Jaehwi Lee, Seok-Yong Lee, Uy Dong Sohn
Korean J Physiol Pharmacol. 2018;22(5):577-584.    doi: 10.4196/kjpp.2018.22.5.577.


Reference

1. Todd JK, Mack AJ. A study of human bladder detrusor muscle. Br J Urol. 1969; 41:448–454. PMID: 5808730.
Article
2. Persson K, Svane D, Glavind B, Uvelius B, Forman A, Andersson KE. Effects of ovariectomy on mechanical properties and collagen content in rabbit lower urinary tract smooth muscle. Scand J Urol Nephrol. 1996; 30:7–14. PMID: 8727858.
Article
3. Wakabayashi Y, Makiura Y, Tomoyoshi T, Kitahama K, Geffard M, Maeda T. Adrenergic innervation of the urinary bladder body in the cat with special reference to structure of the detrusor muscle: an immunohistochemical study of noradrenaline and its synthesizing enzymes. Arch Histol Cytol. 1994; 57:277–289. PMID: 7818951.
Article
4. de Groat WC, Booth AM. Inhibition and facilitation in parasympathetic ganglia of the urinary bladder. Fed Proc. 1980; 39:2990–2996. PMID: 6106562.
5. Raezer DM, Wein AJ, Jacobowitz D, Corriere JN Jr. Autonomic innervation of canine urinary bladder. Cholinergic and adrenergic contributions and interaction of sympathetic and parasympathetic nervous systems in bladder function. Urology. 1973; 2:211–221. PMID: 4583816.
Article
6. Chess-Williams R. Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional. Auton Autacoid Pharmacol. 2002; 22:133–145. PMID: 12452898.
Article
7. Doan TL, Fung HB, Mehta D, Riska PF. Tigecycline: a glycylcycline antimicrobial agent. Clin Ther. 2006; 28:1079–1106. PMID: 16982286.
Article
8. Wright EA, McQuillen MP. Antibiotic-induced neuromuscular blockade. Ann N Y Acad Sci. 1971; 183:358–368. PMID: 4330762.
Article
9. Karataş Y, Ergün Y, Göçmen C, Seçilmiş A, Singirik E, Dikmen A, Baysal F. Possible postsynaptic action of aminoglycosides in the frog rectus abdominis. Acta Med Okayama. 2000; 54:49–56. PMID: 10806525.
10. Burkett L, Bikhazi GB, Thomas KC Jr, Rosenthal DA, Wirta MG, Foldes FF. Mutual potentiation of the neuromuscular effects of antibiotics and relaxants. Anesth Analg. 1979; 58:107–115. PMID: 571233.
Article
11. Paradelis AG, Triantaphyllidis C, Giala MM. Neuromuscular blocking activity of aminoglycoside antibiotics. Methods Find Exp Clin Pharmacol. 1980; 2:45–51. PMID: 6121961.
Article
12. Pittinger C, Adamson R. Antibiotic blockade of neuromuscular function. Annu Rev Pharmacol. 1972; 12:169–184. PMID: 4261048.
Article
13. Corrado AP, de Morais IP, Prado WA. Aminoglycoside antibiotics as a tool for the study of the biological role of calcium ions. Historical overview. Acta Physiol Pharmacol Latinoam. 1989; 39:419–430. PMID: 2520360.
14. Wright JM, Collier B. The effects of neomycin upon transmitter release and action. J Pharmacol Exp Ther. 1977; 200:576–587. PMID: 191590.
15. Smith LR, Meyer G, Lieber RL. Systems analysis of biological networks in skeletal muscle function. Wiley Interdiscip Rev Syst Biol Med. 2013; 5:55–71. PMID: 23188744.
Article
16. Beebe FA, Barkin RL, Barkin S. A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. Am J Ther. 2005; 12:151–171. PMID: 15767833.
Article
17. Ellis KO, Castellion AW, Honkomp LJ, Wessels FL, Carpenter JE, Halliday RP. Dantrolene, a direct acting skeletal muscle relaxant. J Pharm Sci. 1973; 62:948–951. PMID: 4712630.
Article
18. Töröcsik A, Oberfrank F, Sershen H, Lajtha A, Nemesy K, Vizi ES. Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur J Pharmacol. 1991; 202:297–302. PMID: 1748153.
19. Iguchi M, Nakajima T, Hisada T, Sugimoto T, Kurachi Y. On the mechanism of papaverine inhibition of the voltagedependent Ca++ current in isolated smooth muscle cells from the guinea pig trachea. J Pharmacol Exp Ther. 1992; 263:194–200. PMID: 1328605.
20. Santi R, Ferrari M, Contessa AR. On the mechanism of spasmolytic effect of papaverine and certain derivatives. Biochem Pharmacol. 1964; 13:153–158. PMID: 14127294.
Article
21. Altinkurt O, Kanzik I. Inhibitory effects of streptomycin on bronchoconstrictor, hypotensive and inflammatory responses to bradykinin and histamine. Arch Int Pharmacodyn Ther. 1980; 246:277–285. PMID: 7436632.
22. Gergawy M, Vollrath B, Cook D. The mechanism by which aminoglycoside antibiotics cause vasodilation of canine cerebral arteries. Br J Pharmacol. 1998; 125:1150–1157. PMID: 9863641.
Article
23. Hester RK. The effects of gentamicin on tension responses to norepinephrine and KCl and Ca++ binding and fluxes in canine renal vein. Arch Int Pharmacodyn Ther. 1983; 264:118–134. PMID: 6625762.
24. Mogami H, Lloyd Mills C, Gallacher DV. Phospholipase C inhibitor, U73122, releases intracellular Ca2+, potentiates Ins(1,4,5)P3-mediated Ca2+ release and directly activates ion channels in mouse pancreatic acinar cells. Biochem J. 1997; 324:645–651. PMID: 9182729.
25. Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990; 172:993–999. PMID: 2244923.
Article
26. Eckly-Michel AE, Le Bec A, Lugnier C. Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases. Eur J Pharmacol. 1997; 324:85–88. PMID: 9137917.
Article
27. Hague BA, Martinez EA, Hartsfield SM. Effects of high-dose gentamicin sulfate on neuromuscular blockade in halothane-anesthetized horses. Am J Vet Res. 1997; 58:1324–1326. PMID: 9361900.
28. Milanov IG. Mechanisms of baclofen action on spasticity. Acta Neurol Scand. 1992; 85:305–310. PMID: 1621492.
Article
29. Okishio Y, Niioka S, Yamaji M, Yamazaki Y, Nishio H, Takeuchi T, Hata F. Mediators of nonadrenergic, noncholinergic relaxation in Sprague Dawley rat intestine: comparison with the mediators of other strains. J Vet Med Sci. 2000; 62:821–828. PMID: 10993178.
Article
30. Sahin AS, Atalik KE, Dogan N. Nonadrenergic, noncholinergic responses of the rabbit detrusor smooth muscle and the role of L-arginine/nitric oxide pathway in these responses. Methods Find Exp Clin Pharmacol. 2000; 22:31–35. PMID: 10791292.
Article
31. Niioka S, Takeuchi T, Kishi M, Ishii T, Nishio H, Takewaki T, Hata F. Nonadrenergic, noncholinergic relaxation in longitudinal muscle of rat jejunum. Jpn J Pharmacol. 1997; 73:155–161. PMID: 9074949.
32. Jing L, Inoue R, Tashiro K, Takahashi S, Ito Y. Role of nitric oxide in non-adrenergic, non-cholinergic relaxation and modulation of excitatory neuroeffector transmission in the cat airway. J Physiol. 1995; 483:225–237. PMID: 7776234.
Article
33. Lindén A, Löfdahl CG, Ullman A, Skoogh BE. Nonadrenergic, noncholinergic responses stabilize smooth muscle tone, with and without parasympathetic activation, in guinea-pig isolated airways. Eur Respir J. 1993; 6:425–433. PMID: 8472834.
34. Watanabe H, Takahashi R, Zhang XX, Kakizawa H, Hayashi H, Ohno R. Inhibition of agonist-induced Ca2+ entry in endothelial cells by myosin light-chain kinase inhibitor. Biochem Biophys Res Commun. 1996; 225:777–784. PMID: 8780689.
35. Ishikawa T, Chijiwa T, Hagiwara M, Mamiya S, Saitoh M, Hidaka H. ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation. Mol Pharmacol. 1988; 33:598–603. PMID: 3380076.
36. Chiba Y, Takeyama H, Sakai H, Misawa M. Effects of Y-27632 on acetylcholine-induced contraction of intact and permeabilized intrapulmonary bronchial smooth muscles in rats. Eur J Pharmacol. 2001; 427:77–82. PMID: 11553366.
Article
37. Kawada N, Seki S, Kuroki T, Kaneda K. ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. Biochem Biophys Res Commun. 1999; 266:296–300. PMID: 10600496.
Article
38. Thieme H, Nuskovski M, Nass JU, Pleyer U, Strauss O, Wiederholt M. Mediation of calcium-independent contraction in trabecular meshwork through protein kinase C and rho-A. Invest Ophthalmol Vis Sci. 2000; 41:4240–4246. PMID: 11095621.
39. Yoshii A, Iizuka K, Dobashi K, Horie T, Harada T, Nakazawa T, Mori M. Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. Am J Respir Cell Mol Biol. 1999; 20:1190–1200. PMID: 10340938.
Full Text Links
  • KJPP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr